Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Compass Group Diversified Holdings, LLC regarding potential legal action due to undisclosed financial issues related to its subsidiary, Lugano Holding, Inc. [1][2] Group 1: Allegations and Financial Impact - Shareholders who purchased shares of CODI from February 24, 2022, to May 7, 2025, are encouraged to contact the firm for possible lead plaintiff appointment [2] - The complaint alleges that Compass failed to disclose effective internal controls over financial reporting and critical information about Lugano, which had undisclosed financing arrangements and irregularities in sales, cost of sales, inventory, and accounts receivable [2] - Following the announcement on May 7, 2025, that its financial statements for fiscal 2024 could no longer be relied upon, Compass' stock price plummeted from $17.25 per share to $6.55 per share in one day [2] Group 2: Next Steps for Shareholders - The deadline for shareholders to register for the class action is July 8, 2025, and they will be enrolled in a portfolio monitoring software for status updates [3] - There is no cost or obligation for shareholders to participate in the case [3] Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of PepGen Inc. regarding a class action lawsuit due to allegations of misleading statements related to the company's lead product candidate, PGN-EDO51, and its clinical study [1][2]. Group 1: Allegations and Class Action Details - The class period for the allegations is from March 7, 2024, to March 3, 2025 [1]. - Allegations include that PGN-EDO51 was less effective and safe than claimed, and that the CONNECT2 study was dangerous or deficient for FDA approval [1]. - The lawsuit suggests that PepGen may halt the CONNECT2 study, and that the prospects for PGN-EDO51 were overstated [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by August 8, 2025, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

NEW YORK, July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=155244&from=4 CLASS PERIOD: April 29, ...

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=155082&from=3  CLASS PERIOD: ...

Core Viewpoint - The article discusses a class action lawsuit against Krispy Kreme, Inc. (NASDAQ: DNUT) due to allegations of misleading statements regarding the demand for its products at McDonald's locations, which negatively impacted the company's stock performance [1][3]. Summary by Sections Allegations - The complaint alleges that Krispy Kreme's management provided overly positive statements while concealing material adverse facts about declining demand at McDonald's locations, which contributed to a decrease in average weekly sales per store [3]. - The partnership with McDonald's was reportedly unprofitable, leading Krispy Kreme to pause its expansion into new locations [3]. Financial Performance - On February 25, 2025, Krispy Kreme reported disappointing fourth quarter 2024 results, with net revenue of $404 million, a decline of 10.4%, and a decrease in average sales per door per week due to a changing customer mix [3]. - Following this announcement, the stock price fell from $9.13 per share on February 24, 2025, to $7.13 per share on February 25, 2025 [3]. - On May 8, 2025, the company reported first quarter 2025 net revenue of $375.2 million, a decline of 15.3% or $67.5 million, and announced a reassessment of its deployment schedule with McDonald's [3]. - The stock price dropped from $4.33 per share on May 7, 2025, to $3.26 per share on May 8, 2025, marking a decline of about 25% in one day [3]. Next Steps for Shareholders - Shareholders who purchased DNUT shares during the specified class period are encouraged to register for the class action by July 15, 2025, to potentially become lead plaintiffs [4]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of DoubleVerify Holdings, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during the class period from November 10, 2023, to February 27, 2025 [1][3]. Allegations - The complaint alleges that DoubleVerify's customers shifted ad spending from open exchanges to closed platforms, where the company's technological capabilities were limited, impacting its competitive position against platforms like Meta and Amazon [3]. - It is claimed that DoubleVerify's ability to monetize its Activation Services was constrained due to the high costs and time required for technology development for closed platforms, which were not adequately disclosed to investors [3]. - The lawsuit states that monetization of DoubleVerify's Activation Services on certain closed platforms would take several years, contrary to what was communicated to shareholders [3]. - Competitors were reportedly better positioned to integrate AI into their offerings on closed platforms, negatively affecting DoubleVerify's competitiveness and profitability [3]. - The company allegedly overbilled customers for ad impressions served to bots, which were known to operate from data center server farms [3]. - The risk disclosures provided by DoubleVerify were claimed to be materially false and misleading, as they downplayed already materialized adverse facts [3]. - As a result of these issues, the positive statements made by the defendants regarding the company's business and prospects were deemed materially false or misleading [3]. Next Steps for Shareholders - Shareholders who purchased shares of DoubleVerify during the specified class period are encouraged to register for the class action by July 21, 2025, to participate in potential recovery [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of West Pharmaceutical Services, Inc. regarding a class action lawsuit due to alleged misleading statements and operational inefficiencies that negatively impacted the company's financial performance during the specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from February 16, 2023, to February 12, 2025 [3]. - Allegations include: - West Pharmaceutical Services claimed strong visibility into customer demand while actually facing significant destocking in its high-margin HVP portfolio [3]. - The SmartDose device, marketed as a high-margin growth product, was found to be dilutive to profit margins due to operational inefficiencies [3]. - Margin pressures raised the risk of costly restructuring activities, including exiting continuous glucose monitoring contracts with long-term customers [3]. - Positive statements made by the defendants regarding the company's business and prospects were materially false or misleading [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 7, 2025, to participate in potential recovery [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [5]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated the company's stock price [5].

NEW YORK, June 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG).Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/pepgen-inc-loss-submission-form/?id=154641&from=4 CLASS PERIOD: March 7, 2024 to March 3, 202 ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Digimarc Corporation regarding a class action lawsuit due to alleged misleading statements and omissions by the company during a specified class period [1][2]. Group 1: Allegations - The complaint alleges that Digimarc failed to disclose that a significant commercial partner would not renew a large contract on the same terms [1]. - As a result of the non-renewal, Digimarc would need to renegotiate the large commercial contract, adversely affecting the company's subscription revenue and annual recurring revenue [1]. - The defendants' positive statements about the company's business and prospects were claimed to be materially misleading or lacked a reasonable basis due to these issues [1]. Group 2: Class Action Details - The class period for the lawsuit is from May 3, 2024, to February 26, 2025 [1]. - Shareholders are encouraged to register for the class action by July 7, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

NEW YORK, June 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fortrea Holdings Inc. (NASDAQ: FTRE).Shareholders who purchased shares of FTRE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/fortrea-holdings-inc-loss-submission-form/?id=154639&from=4 CLASS PERIOD: July 3, 2 ...